Belgian Start-up UgenTec Receives Funding from European Investors

14-Apr-2015 - Belgium

UgenTec, a start-up company based in Belgium that develops laboratory software for automating PCR based DNA analysis, announced that it has received more than €1m in venture capital funding from a group of Belgian investors and an additional €250,000 in research funds from the IWT, a government agency for Innovation by Science and Technology. The investors include former MedHold (now part of Sonic Healthcare) CEO Annie Vereecken, Cartagenia CEO Herman Verrelst and a KULeuven investment group led by prof. Bart De Moor. LRM, a Belgian investment company will also support UgenTec with a loan of €100,000.

UgenTec will use the new funds for software development, international expansion including preparation for commercialization in the U.S. and recruitment, noted Wouter Uten, CEO of UgenTec.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy